Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duac Gel versus Differin Gel for mild to moderate acne vulgaris
2005-004708-35Phase 4Withdrawn
- Sponsor
- Stiefel Laboratories
- Start
- Jun 2007
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in acne vulgaris comparing Duac Gel once daily with Differin Gel once daily (2 arms). Primary endpoint: Change from baseline in subject quality of life score at week 2. Planned start Jun 2007; status: withdrawn.
02
Drugs
clindamycin phosphate + benzoyl peroxideadapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2005-004708-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004708-35.